You are here » Home » Companies » Company Overview » Transgene Biotek Ltd

Transgene Biotek Ltd.

BSE: 526139 Sector: Health care
NSE: N.A. ISIN Code: INE773D01018
BSE 15:01 | 27 Jan 3.58 0.16
(4.68%)
OPEN

3.42

HIGH

3.59

LOW

3.25

NSE 05:30 | 01 Jan Transgene Biotek Ltd
OPEN 3.42
PREVIOUS CLOSE 3.42
VOLUME 20890
52-Week high 5.93
52-Week low 3.03
P/E
Mkt Cap.(Rs cr) 27
Buy Price 3.30
Buy Qty 90.00
Sell Price 3.58
Sell Qty 3045.00
OPEN 3.42
CLOSE 3.42
VOLUME 20890
52-Week high 5.93
52-Week low 3.03
P/E
Mkt Cap.(Rs cr) 27
Buy Price 3.30
Buy Qty 90.00
Sell Price 3.58
Sell Qty 3045.00

Transgene Biotek Ltd. (TRANSGENEBIOTEK) - Company History

Transgene Biotek was incorporated as a private limited company in Mar.'90 and was converted into a public limited company in Nov.'90.The company is engaged in the research and development and manufacture of various medical reagents both chemical and immuno-diagnostic reagents for the qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.Transgene Biotek's products are exported to Africa Russia China Malaysia and the Phillipines. The company chalked out a new project for setting up a manufacturing facility at a cost of Rs.30 crore at the Anrich Industrial AreaBollaram. TBL is working of four new plants:Oral deliver of proteins and peptides:DNA vaccines:fusion proteins and bio therapeutics. The new project is being funded by way of preferential offer to Batterymarch Financial management USA and other financial institutions.

.